Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate (dimethylamino-hydroxyproylidene bisphosphonate)
Landsmeer-Beker EA, Massa GG, Maaswinkel-Mooy PD, van de Kemp JJ, Papapoulos SE,
Eur J Pediatr
1997
156
792-794
en
Treatment of ??ulmonary alveolar microlithiasis with a diphosphonate - preliminary results of a case
Gocmen A, Toppare MF, Kiper N, Buyukpamukcu N,
Respiration
1992
59
250-252
en
Torsion of a functional ovarian cyst in a premenopausal patient receiving tamoxifen
Nasu K, Miyazaki T, Kiyonaga Y, Kawasaki J, Miyakawa I,
Gynecol Obstet Invest
1999
48
200-202
en
The use of pamidronate in PTHrP associated hypercalcaemia in infancy
Buckmaster A, Rodda C, Cowell CT, Ogle G, Dorney S,
Journal of Pediatric Endocrinology & Metabolism (JPEM)
1997
10
301-304
en
The stimulatory G protein alpha-subunit gene: mutations and imprintig lead to complex phenotypes
Weinstein Ls,
J Clin Endocrinol Metab
2001
86
4622-4626
en
The natural history of fibrous dysplasia
Harris WH, Dudley HR Jr, Barry RJ,
J Bone Joint Surg
1962
44-A
207-233
en
The natural history of autonomous gonadal function, adrenarche, and central puberty in gonadotropin-indipendent precocious puberty in gonadotropin-independent precocious puberty
The McCune-Albright syndrome: a lethal gene surviving by mosaicism
Happle R,
Clin Genet
1986
29
321-324
en
The McCune-Albright syndrome
Mauras N., Blizzard RM,
Acta Endocirnol (Copenh)
1986
279
207-217
en
The luteinizing hormone receptor
Dufau ML,
Annu Rev Physiol
1998
60
461-496
en
The human thyrotropin receptor is highly mutable: a review of gain-of-function mutation
Farid NR, Kascur V, Balazs C,
Eur J Endocrinol
2000
143
25-30
en
The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gsalpha gene: site- specific patterns and recurrent histological hallmarks
Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Robey PG, Bianco P,
J Pathol
1999
187
249-258
en
The GTPase superfamily: a conserved switch for diverse cell functions
